MedUX Insights
5G QoE Benchmarking Report
An analysis of 5G performance and Quality of Experience in London (Q3 2023)
Speed is not everything and the industry is trying to adapt to meet the needs of customers when using real services. Typical end-users do not necessarily benefit much from download speeds of multiple 100Mbps (not yet). End-users just use a small percentage of those headline speeds when web browsing, streaming and any other internet regular activities.
Indeed, some experience categories such as Reliability (how consistent a network performs) or CDN performance (how your contents are served) are way more relevant in the 5G Era than just performing a throughput and ping test against (optimized) test servers to infer the customer experience.
In this report, related to our our Blog Post "London's 5G Dilemma: EE Outshines locally, but London's Average Experience Is Worst Among European Cities", you will find:
Our report reveals in the analysis of the real field 5G measurements and true QoE KPIs that some operators have a better experience while others do not so much according to 5G expectations.
Upon approval of your request, you will receive a confirmation email containing a link to download the report. Please note that an active work email address is required to receive the report. If you did not provide a correct work email, we kindly ask you to review and update your request accordingly.
MedUX is planning to perform this benchmarking campaign on a recurring basis, and even enable certain continuous 24/7 measurements in particular geographies on-demand. Discover more by reaching out to us at hello@medux.com to explore potential collaborations in upcoming campaigns.
In the meantime, you may also want to have a look at our recent Blog Post and download a copy of our report about 5G Experience in Europe: "All 5G networks are not created equal: Unveiling the TRUE QoE of 5G in Europe (II)".
ALL RIGHTS RESERVED. This article or report has been prepared for the exclusive use and benefit of press media and solely for non-commercial purposes. Press media members are authorized to entirely or partially disseminate, refer, quote, copy, reproduce, distribute, publish and transfer the report and its findings (including all intellectual property rights, data, content graphs and analysis) for information purposes with express attribution to MedUX. Use of the report and its findings, entirely or partially, in any form or by any means, by any other third party or for any other purposes (including, commercial or marketing purposes), without the prior written consent of MedUX, is strictly prohibited. Operators can make a request to MedUX for a license to use quality or certification seals, as well as marketing rights to quote the findings. Non-authorized use will be considered a violation of copyright and trademarks laws.